Healthcare & Life Sciences

EnLiven Therapeutics

series-c-plus
series-c-plus
Stage
1
Investors

About

EnLiven Therapeutics is a biopharmaceutical company focused on developing novel therapeutics to treat fibrotic diseases.

Explore EnLiven Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.